← Evidence map

ArticleBreast (Edinburgh, Scotland)2025

Corrigendum to "Metronomic chemotherapy using capecitabine and cyclophosphamide in metastatic breast cancer - efficacy, tolerability and quality of life results from the phase II METRO trial" [The Breast 78 (2004) 103795].

Karolina Larsson F et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Corrigendum to "Metronomic chemotherapy using capecitabine and cyclophosphamide in metastatic breast cancer - efficacy, tolerability and quality of life results from the phase II METRO trial" [The Breast 78 (2004) 103795]. | OpenQuestion